Thuy Tran

Work summary:

I obtained a PhD in 2009 from Uppsala University and received my Docent/readership in 2016 from Lund University in experimental oncology with a focus on molecular imaging and radiochemistry. 

I have more than 15 years’ experience in both preclinical and clinical research in the fields of nuclear medicine, radionuclide production, molecular imaging, and antibody-based theranostics. Currently, I lead the TRANslational Theranostics group, which is dedicated to advancing theranostics - an elegant approach that seamlessly integrates diagnostics and therapy in one solution, revolutionizing precision medicine in cancer management. Clinically, I am heading the newly established Theranostics Trial Center at Karolinska since 2024, where the focus is to translate radiopharmaceutical developmens from bench to bedside. 

Education summary:
2005 Master of Science in Pharmacy, Uppsala University

2008 Master Degree in Medical radionuclide techniques, Uppsala University

2009 Ph.D. Degree, specialized in Molecular imaging and radiometal chemistry, Uppsala University

2016 Docent in experimental oncology, Lund University

My research group focuses on the development of theranostics, i.e. radiopharmaceuticals for precision diagnostics, therapy and monitoring of diseases, with the emphasis in oncological diseases. We conduct studies to identify new targets and screen for new drugs for cancer treatments. In parallel, we perform novel developments of non-conventional radiometals using solid target on cyclotron, novel radiotracer developments, and biological evaluation studies in vitro and in vivo to clinical translation.

We are a multidisciplinary team consisting of pharmacists, radiochemists, medicine doctoral students, medical physicists, biologists and oncologist. We collaborate closely and broadly with other research groups for generating drug screening, target identification, and clinicians, oncologists, and radiologists for clinical translation.

> 160 hrs of teaching since 2010, in cluding teaching, lecturing and supervision on different courses on basic, advanced, doctoral and specialist levels.

> Course responsible for "Radiofarmaka, 3 hp" in Bachelor's program in Biomedicine from 2025.